Litcius/Paper detail

Drug‐induced peripheral oedema: An aetiology‐based review

Bérenger Largeau, Jean‐Luc Cracowski, Céline Lengellé, Bénédicte Sautenet, A.‐P. Jonville‐Béra

2021British Journal of Clinical Pharmacology82 citationsDOIOpen Access PDF

Abstract

Many drugs are responsible, through different mechanisms, for peripheral oedema. Severity is highly variable, ranging from slight oedema of the lower limbs to anasarca pictures as in the capillary leak syndrome. Although most often noninflammatory and bilateral, some drugs are associated with peripheral oedema that is readily erythematous (eg, pemetrexed) or unilateral (eg, sirolimus). Thus, drug-induced peripheral oedema is underrecognized and misdiagnosed, frequently leading to a prescribing cascade. Four main mechanisms are involved, namely precapillary arteriolar vasodilation (vasodilatory oedema), sodium/water retention (renal oedema), lymphatic insufficiency (lymphedema) and increased capillary permeability (permeability oedema). The underlying mechanism has significant impact on treatment efficacy. The purpose of this review is to provide a comprehensive analysis of the main causative drugs by illustrating each pathophysiological mechanism and their management through an example of a drug.

Topics & Concepts

MedicinePeripheral edemaEdemaPeripheralDrugLymphedemaVascular permeabilityEtiologyPharmacologyInternal medicineAnesthesiaAdverse effectCancerBreast cancerCancer Treatment and PharmacologyPharmacology and Obesity TreatmentSympathectomy and Hyperhidrosis Treatments
Drug‐induced peripheral oedema: An aetiology‐based review | Litcius